Dynavax Technologies Corporation 0IDA.L Stock
Dynavax Technologies Corporation Price Chart
Dynavax Technologies Corporation 0IDA.L Financial and Trading Overview
| Dynavax Technologies Corporation stock price | 11.8 USD |
| Previous Close | 12.54 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 17.36 USD |
| Volume | 3.51K USD |
| Avg. Volume | 803 USD |
| Market Cap | 2.74M USD |
| Beta (5Y Monthly) | 1.484507 |
| PE Ratio (TTM) | 0.17196546 |
| EPS (TTM) | 0.75 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0IDA.L Valuation Measures
| Enterprise Value | 1.23B USD |
| Trailing P/E | 0.17196546 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.00418389 |
| Price/Book (mrq) | 2.9510028 |
| Enterprise Value/Revenue | 1.884 |
| Enterprise Value/EBITDA | 4.62 |
Trading Information
Dynavax Technologies Corporation Stock Price History
| Beta (5Y Monthly) | 1.484507 |
| 52-Week Change | 24.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 17.36 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 10.69 USD |
| 200-Day Moving Average | 11.82 USD |
0IDA.L Share Statistics
| Avg. Volume (3 month) | 803 USD |
| Avg. Daily Volume (10-Days) | 551 USD |
| Shares Outstanding | 62.69M |
| Float | 121.64M |
| Short Ratio | N/A |
| % Held by Insiders | 0.23% |
| % Held by Institutions | 92.94% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 35.99% |
| Operating Margin (ttm) | 40.18% |
| Gross Margin | 61.60% |
| EBITDA Margin | 40.77% |
Management Effectiveness
| Return on Assets (ttm) | 16.64% |
| Return on Equity (ttm) | 55.44% |
Income Statement
| Revenue (ttm) | 655.62M USD |
| Revenue Per Share (ttm) | 5.15 USD |
| Quarterly Revenue Growth (yoy) | -58.79% |
| Gross Profit (ttm) | 448.22M USD |
| EBITDA | 267.31M USD |
| Net Income Avi to Common (ttm) | 235.81M USD |
| Diluted EPS (ttm) | 0.753 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 651.96M USD |
| Total Cash Per Share (mrq) | 5.07 USD |
| Total Debt (mrq) | 257.82M USD |
| Total Debt/Equity (mrq) | 45.73 USD |
| Current Ratio (mrq) | 9.071 |
| Book Value Per Share (mrq) | 4.388 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 140.78M USD |
| Levered Free Cash Flow (ttm) | 78.86M USD |
Profile of Dynavax Technologies Corporation
| Country | United Kingdom |
| State | CA |
| City | EmeryVille |
| Address | 2100 Powell Street |
| ZIP | 94608 |
| Phone | 510 848 5100 |
| Website | https://www.dynavax.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 351 |
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Q&A For Dynavax Technologies Corporation Stock
What is a current 0IDA.L stock price?
Dynavax Technologies Corporation 0IDA.L stock price today per share is 11.8 USD.
How to purchase Dynavax Technologies Corporation stock?
You can buy 0IDA.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dynavax Technologies Corporation?
The stock symbol or ticker of Dynavax Technologies Corporation is 0IDA.L.
How many shares does Dynavax Technologies Corporation have in circulation?
The max supply of Dynavax Technologies Corporation shares is 211.83K.
What is Dynavax Technologies Corporation Price to Earnings Ratio (PE Ratio)?
Dynavax Technologies Corporation PE Ratio is 0.15670650 now.
What was Dynavax Technologies Corporation earnings per share over the trailing 12 months (TTM)?
Dynavax Technologies Corporation EPS is 0.75 USD over the trailing 12 months.